Burundi Launches #ABREMA: Fully Digital Platform for Pharmaceutical Imports
The introduction of #ABREMA is expected to save considerable time for importers by eliminating lengthy physical procedures of the past.
The Office Burundais des Recettes (OBR) announced on February 17, 2026, the launch and operationalization of its web module #ABREMA, a fully digital platform designed to streamline the importation of pharmaceutical products through an electronic one-stop shop. Launched initially in 2021, the platform represents a significant milestone in Burundi’s efforts to modernize customs and import processes.
The #ABREMA system offers several key benefits for drug importers. It fully digitizes the process, covering everything from membership and permit applications to the actual importation of pharmaceutical products. An interactive dashboard allows users to track the status of their import permits, while fees are calculated automatically with the option to pay in multiple currencies. The platform also enhances security in user management, ensuring safe and reliable access for all stakeholders.
This innovation is the result of a collaborative effort between ABREMA, the OBR, commercial banks, and customs agencies, supported financially by Trade Mark Africa and technically by UNUCED. Deputy Commissioner General of OBR, Mr. Georges Bigirimana, expressed his gratitude to all partners involved in bringing the platform to fruition.
The introduction of #ABREMA is expected to save considerable time for importers by eliminating lengthy physical procedures of the past. Exclusive use of the platform began on February 18, 2026, and all users are now required to register and use it for importing designated pharmaceutical products.
